Literature DB >> 23818649

Right ventricular hypertrophy and failure abolish cardioprotection by ischaemic pre-conditioning.

Asger Andersen1, Jonas Agerlund Povlsen, Hans Erik Bøtker, Jens Erik Nielsen-Kudsk.   

Abstract

AIMS: We aimed to investigate the response to ischaemia-reperfusion (IR) and ischaemic pre-conditioning (IPC) in the hypertrophic and failing right heart. METHODS AND
RESULTS: Male Wistar rats underwent sham operation, moderate pulmonary trunk banding (mPTB), or severe PTB (sPTB). Four weeks after surgery, hearts were quick-frozen (n = 28) for biochemical analysis of key salvage pathways or isolated and perfused in a Langendorff set-up (n = 46). We randomized perfused hearts to IPC (2 × 5 min of global ischaemia) or no preceding ischaemia (CON), before 40 min of global ischaemia and 120 min of reperfusion. The infarct size/area at risk (IS/AAR) ratio and post-ischaemic right ventricular (RV) function were used to evaluate the effect of IPC. mPTB induced compensated RV hypertrophy and sPTB induced RV hypertrophy with failure. Hypertrophy of the right ventricle increased IS in hearts from mPTB and sPTB animals compared with sham (IS/AAR, 73.1 ± 2.9% and 59.3 ± 2.4% vs. 35.6 ± 2.9%, P < 0.0001). IPC reduced IS in sham and mPTB hearts (IS/AAR, 35.6 ± 2.9% vs. 17.4 ± 1.2% and 73.1 ± 2.9% vs. 56.9 ± 3.5%, P < 0.01) and improved recovery of RV contractile function. IPC did not alter IS/AAR (59.3 ± 2.4% and 59.3 ± 2.9%, P = 0.999) or haemodynamic recovery in sPTB hearts. RV cyclic guanosine monophosphate (cGMP) and the cGMP-dependent protein kinase were increased after sPTB.
CONCLUSION: Right ventricular hypertrophy increases IR injury. Cardioprotection by IPC is abolished in the failing but not the compensated hypertrophic right ventricle of the rat heart.

Entities:  

Keywords:  Cardioprotection; Congenital heart disease; Heart failure; Ischaemia–reperfusion injury; Right ventricle

Mesh:

Year:  2013        PMID: 23818649     DOI: 10.1093/eurjhf/hft105

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  6 in total

Review 1.  Hexokinases and cardioprotection.

Authors:  Guillaume Calmettes; Bernard Ribalet; Scott John; Paavo Korge; Peipei Ping; James N Weiss
Journal:  J Mol Cell Cardiol       Date:  2014-09-26       Impact factor: 5.000

2.  Hypertrophic preconditioning: short-term tricks for long-term gain.

Authors:  Arjun Deb; Yibin Wang
Journal:  Circulation       Date:  2015-03-27       Impact factor: 29.690

Review 3.  Pressure-overload-induced right heart failure.

Authors:  S Rain; M L Handoko; A Vonk Noordegraaf; H J Bogaard; J van der Velden; F S de Man
Journal:  Pflugers Arch       Date:  2014-02-01       Impact factor: 3.657

Review 4.  Cardioprotection in right heart failure.

Authors:  Kerstin Boengler; Klaus-Dieter Schlüter; Ralph Theo Schermuly; Rainer Schulz
Journal:  Br J Pharmacol       Date:  2020-03-09       Impact factor: 8.739

5.  Clinically-relevant consecutive treatment with isoproterenol and adenosine protects the failing heart against ischaemia and reperfusion.

Authors:  Igor Khaliulin; Andrew P Halestrap; Simon M Bryant; Declan J Dudley; Andrew F James; M-Saadeh Suleiman
Journal:  J Transl Med       Date:  2014-05-21       Impact factor: 5.531

Review 6.  Novel Roles of Non-Coding RNAs in Opioid Signaling and Cardioprotection.

Authors:  Zesergio Melo; Cecilia Ishida; Maria de la Paz Goldaraz; Rocio Rojo; Raquel Echavarria
Journal:  Noncoding RNA       Date:  2018-09-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.